This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Dec 18;376(9758):2069; author reply 2069-70.

doi: 10.1016/S0140-6736(10)62286-6.

Ivabradine and outcomes in chronic heart failure

Seok-Min Kang, Hoyoun Won, Namki Hong, Jaewon Oh

PMID: 21168043
DOI: 10.1016/S0140-6736(10)62286-6

Comment

Ivabradine and outcomes in chronic heart failure

Seok-Min Kang et al. Lancet. 2010.

. 2010 Dec 18;376(9758):2069; author reply 2069-70.

doi: 10.1016/S0140-6736(10)62286-6.

Authors

Seok-Min Kang, Hoyoun Won, Namki Hong, Jaewon Oh

PMID: 21168043
DOI: 10.1016/S0140-6736(10)62286-6

No abstract available

PubMed Disclaimer

Comment on

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Swedberg K, et al. Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Lancet. 2010. PMID: 20801500 Clinical Trial.

Similar articles

Ivabradine and outcomes in chronic heart failure.
Gupta A, Sharma YP. Gupta A, et al. Lancet. 2010 Dec 18;376(9758):2069; author reply 2069-70. doi: 10.1016/S0140-6736(10)62285-4. Lancet. 2010. PMID: 21168044 No abstract available.
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Swedberg K, et al. Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Lancet. 2010. PMID: 20801500 Clinical Trial.
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Böhm M, et al. Lancet. 2010 Sep 11;376(9744):886-94. doi: 10.1016/S0140-6736(10)61259-7. Lancet. 2010. PMID: 20801495 Clinical Trial.
The Use and Indication of Ivabradine in Heart Failure.
Dodd K, Lampert BC. Dodd K, et al. Heart Fail Clin. 2018 Oct;14(4):493-500. doi: 10.1016/j.hfc.2018.06.001. Epub 2018 Aug 18. Heart Fail Clin. 2018. PMID: 30266358 Review.
Role of ivabradine and heart rate lowering in chronic heart failure: guideline update.
Chow SL, Page RL 2nd, Depre C. Chow SL, et al. Expert Rev Cardiovasc Ther. 2018 Jul;16(7):515-526. doi: 10.1080/14779072.2018.1489235. Epub 2018 Jul 2. Expert Rev Cardiovasc Ther. 2018. PMID: 29902387 Review.

See all similar articles

Cited by

Etiology-specific assessment of predictors of long-term survival in chronic systolic heart failure.
Franke J, Zugck C, Hochadel M, Hack A, Frankenstein L, Zhao JD, Ehlermann P, Nelles M, Zeymer U, Winkler R, Zahn R, Katus HA, Senges J. Franke J, et al. Int J Cardiol Heart Vasc. 2015 Feb 26;7:61-68. doi: 10.1016/j.ijcha.2015.01.015. eCollection 2015 Jun 1. Int J Cardiol Heart Vasc. 2015. PMID: 28785647 Free PMC article.
The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients.
Barzilai M, Jacob G. Barzilai M, et al. Rambam Maimonides Med J. 2015 Jul 30;6(3):e0028. doi: 10.5041/RMMJ.10213. Rambam Maimonides Med J. 2015. PMID: 26241226 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information